Volumetric evaluation of upper airway in obstructive sleep apnea
- Conditions
- G47.3Sleep apnoea
- Registration Number
- DRKS00005948
- Lead Sponsor
- niversity of Araraquara
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Adult patients medical records from the Otorhinolaryngology Clinics of the Medical School of the Araraquara University Center- UNIARA
Exclusion Criteria
morbid obesity (IMC>40); craniofacial abnormalities such as craniodysostoses, craniostenosis, meningomyelocele and craniofacial cleft; nasal obstruction by polyposis or nasal tumor; existence of any craniofacial or airway tumor; larynx or pharynx paralysis; and previous upper airway surgery.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie upper airway volume changes in obstructive sleep apnea as studied in DRKS00005948?
How does volumetric analysis in DRKS00005948 compare to standard-of-care diagnostic methods for G47.3 sleep apnoea?
Are there specific biomarkers identified in DRKS00005948 that correlate with severity or response to treatment in obstructive sleep apnea?
What adverse events are associated with upper airway volumetric evaluation techniques in obstructive sleep apnea research?
What are the implications of DRKS00005948 findings on current therapeutic strategies involving CPAP or oral appliances for sleep apnoea?